n-(2-(dimethylamino)ethyl)-n-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1h-purin-8-yl)benzenesulfonamide has been researched along with Injury, Myocardial Reperfusion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beier, N; Gross, GJ; Gumina, RJ; Schelling, P | 1 |
1 other study(ies) available for n-(2-(dimethylamino)ethyl)-n-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1h-purin-8-yl)benzenesulfonamide and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Inhibitors of ischemic preconditioning do not attenuate Na+/H+ exchange inhibitor mediated cardioprotection.
Topics: Animals; Benzamides; Dogs; Female; Glyburide; Hemodynamics; Hypoglycemic Agents; Ischemic Preconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Purines; Pyrroles; Sodium-Hydrogen Exchangers; Sulfonamides | 2000 |